Russell Investments Group, Ltd.
Position in CATX — Perspective Therapeutics, Inc.
CIK 1692234
Seattle, WA
Position in CATX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$135,928
+$100,580 QoQ
Shares Held
39,862
+370.2% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 130 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,038,978,428 across 88 Medical Devices names. CATX ranks #67 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
2,288,745 | $207,039,863 | |
| 2 | MDT |
Medtronic plc
|
1,750,957 | $136,977,358 | |
| 3 | SYK |
Stryker Corp
|
420,962 | $132,535,668 | |
| 4 | ABT |
Abbott Laboratories
|
1,380,872 | $125,300,317 | |
| 5 | BSX |
Boston Scientific Corp
|
2,895,696 | $123,588,298 | |
| 6 | DXCM |
Dexcom Inc
|
973,800 | $65,585,423 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
662,351 | $42,397,082 | |
| 8 | PODD |
Insulet Corp
|
163,842 | $24,944,937 |
All Filings in CATX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $135,928 | 39,862 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $35,348 | 8,477 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $23,311 | 8,477 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $28,979 | 8,449 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $10,230 | 2,974 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,697 | 1,736 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,702 | 2,101 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||